Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis
Abstract Background Rheumatoid arthritis (RA) generates an inflammatory profile that predisposes to total and visceral fatty accumulation and reduced fat free mass (FFM). This metabolic disorder contributes to poor functionality, increased cardiovascular risk and higher mortality. This study aimed t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-05-01
|
| Series: | Advances in Rheumatology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42358-022-00249-0 |
| _version_ | 1818213509697110016 |
|---|---|
| author | Mariana Peixoto Guimarães Ubirajara e Silva de Souza Nathalia Sernizon Guimarães Maria Fernanda Brandão de Resende Guimarães Viviane Angelina de Souza Adriana Maria Kakehasi |
| author_facet | Mariana Peixoto Guimarães Ubirajara e Silva de Souza Nathalia Sernizon Guimarães Maria Fernanda Brandão de Resende Guimarães Viviane Angelina de Souza Adriana Maria Kakehasi |
| author_sort | Mariana Peixoto Guimarães Ubirajara e Silva de Souza |
| collection | DOAJ |
| description | Abstract Background Rheumatoid arthritis (RA) generates an inflammatory profile that predisposes to total and visceral fatty accumulation and reduced fat free mass (FFM). This metabolic disorder contributes to poor functionality, increased cardiovascular risk and higher mortality. This study aimed to address a systematic review with meta-analysis to determine the effect of biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) on body composition (BC) of patients with RA. Methods The search was conducted at the electronic databases PubMed, Cochrane Library, Embase, Lilacs and grey literature. This investigation was carried until July 2021. Outcomes of interest were total weight, body mass index (BMI), fat mass (FM) and FFM. A meta-analysis comparing these outcomes in RA patients under bDMARD treatment versus controls was performed. Results Out of 137 studies reviewed, 18 were selected: fifteen prospective cohorts, two retrospective cohorts, and one cross-sectional study. The studies comprised 1221 patients, 778 on bDMARD treatment and 443 controls, which included RA patients under conventional synthetic DMARD (csDMARD). No study addressing BC analysis in patients using tsDMARD was found. The mean age and duration of the disease was 56.7 years and 6.77 years, respectively. Ten studies demonstrated a significant increase of total weight in 88.2% of patients and 42.3% for BMI. In studies that analyzed BC by double X-ray absorptiometry (DXA), the increase in total weight and BMI correlated positively to the increase in FFM. The meta-analysis carried out in five studies showed no significant difference of the mean difference for total weight 0.12 kg (95% CI − 5.58, 5.82), BMI 0.08 kg/m2 (95% CI − 1.76, 1.92), FM − 0.08 kg (95% IC − 5.31, 5.14), and FFM − 2.08 kg (95% CI − 7.37, 3.21). Conclusion This systematic review suggests a possible impact of bDMARDs on BC of RA patients, even though, the meta-analysis carried out in a small part of these studies was not able to confirm significant variation in BC components. Trial registration: PROSPERO code: CRD42020206949. |
| first_indexed | 2024-12-12T06:05:25Z |
| format | Article |
| id | doaj.art-30d832c64230422089ab0f9874175faf |
| institution | Directory Open Access Journal |
| issn | 2523-3106 |
| language | English |
| last_indexed | 2024-12-12T06:05:25Z |
| publishDate | 2022-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Advances in Rheumatology |
| spelling | doaj.art-30d832c64230422089ab0f9874175faf2022-12-22T00:35:18ZengBMCAdvances in Rheumatology2523-31062022-05-0162111010.1186/s42358-022-00249-0Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysisMariana Peixoto Guimarães Ubirajara e Silva de Souza0Nathalia Sernizon Guimarães1Maria Fernanda Brandão de Resende Guimarães2Viviane Angelina de Souza3Adriana Maria Kakehasi4Post Graduate Program in Sciences Applied to Adult Health Care, Federal University of Minas GeraisCollective Health Institute of the Federal University of BahiaPost Graduate Program in Sciences Applied to Adult Health Care, Federal University of Minas GeraisFederal University of Juiz de For aPost Graduate Program in Sciences Applied to Adult Health Care, Federal University of Minas GeraisAbstract Background Rheumatoid arthritis (RA) generates an inflammatory profile that predisposes to total and visceral fatty accumulation and reduced fat free mass (FFM). This metabolic disorder contributes to poor functionality, increased cardiovascular risk and higher mortality. This study aimed to address a systematic review with meta-analysis to determine the effect of biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) on body composition (BC) of patients with RA. Methods The search was conducted at the electronic databases PubMed, Cochrane Library, Embase, Lilacs and grey literature. This investigation was carried until July 2021. Outcomes of interest were total weight, body mass index (BMI), fat mass (FM) and FFM. A meta-analysis comparing these outcomes in RA patients under bDMARD treatment versus controls was performed. Results Out of 137 studies reviewed, 18 were selected: fifteen prospective cohorts, two retrospective cohorts, and one cross-sectional study. The studies comprised 1221 patients, 778 on bDMARD treatment and 443 controls, which included RA patients under conventional synthetic DMARD (csDMARD). No study addressing BC analysis in patients using tsDMARD was found. The mean age and duration of the disease was 56.7 years and 6.77 years, respectively. Ten studies demonstrated a significant increase of total weight in 88.2% of patients and 42.3% for BMI. In studies that analyzed BC by double X-ray absorptiometry (DXA), the increase in total weight and BMI correlated positively to the increase in FFM. The meta-analysis carried out in five studies showed no significant difference of the mean difference for total weight 0.12 kg (95% CI − 5.58, 5.82), BMI 0.08 kg/m2 (95% CI − 1.76, 1.92), FM − 0.08 kg (95% IC − 5.31, 5.14), and FFM − 2.08 kg (95% CI − 7.37, 3.21). Conclusion This systematic review suggests a possible impact of bDMARDs on BC of RA patients, even though, the meta-analysis carried out in a small part of these studies was not able to confirm significant variation in BC components. Trial registration: PROSPERO code: CRD42020206949.https://doi.org/10.1186/s42358-022-00249-0Rheumatoid arthritisBody compositionDisease-modifying antirheumatic drugsRheumatoid cachexiaFat free mass |
| spellingShingle | Mariana Peixoto Guimarães Ubirajara e Silva de Souza Nathalia Sernizon Guimarães Maria Fernanda Brandão de Resende Guimarães Viviane Angelina de Souza Adriana Maria Kakehasi Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis Advances in Rheumatology Rheumatoid arthritis Body composition Disease-modifying antirheumatic drugs Rheumatoid cachexia Fat free mass |
| title | Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| title_full | Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| title_fullStr | Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| title_full_unstemmed | Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| title_short | Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis |
| title_sort | effect of biological disease modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis a systematic review and meta analysis |
| topic | Rheumatoid arthritis Body composition Disease-modifying antirheumatic drugs Rheumatoid cachexia Fat free mass |
| url | https://doi.org/10.1186/s42358-022-00249-0 |
| work_keys_str_mv | AT marianapeixotoguimaraesubirajaraesilvadesouza effectofbiologicaldiseasemodifyingantirheumaticdrugsonbodycompositioninpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT nathaliasernizonguimaraes effectofbiologicaldiseasemodifyingantirheumaticdrugsonbodycompositioninpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT mariafernandabrandaoderesendeguimaraes effectofbiologicaldiseasemodifyingantirheumaticdrugsonbodycompositioninpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT vivianeangelinadesouza effectofbiologicaldiseasemodifyingantirheumaticdrugsonbodycompositioninpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT adrianamariakakehasi effectofbiologicaldiseasemodifyingantirheumaticdrugsonbodycompositioninpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis |